Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosomal translocations in human cancer

T H Rabbitts1

  • 1MRC Laboratory of Molecular Biology, Cambridge, UK.

Nature
|November 10, 1994
PubMed
Summary

Chromosomal abnormalities, particularly translocations, create fusion proteins in cancers. These proteins, often transcription factors, drive cancer development and represent promising therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intracellular Antibodies for Drug Discovery and as Drugs of the Future.

Antibodies (Basel, Switzerland)·2023
Same author

LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia.

Leukemia·2016
Same author

Selection of human single domain antibodies recognizing the CMYC protein using enhanced intracellular antibody capture.

Journal of immunological methods·2015
Same author

Antibody diversification by somatic mutation.

Immunology today·2014
Same author

Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complex.

Scientific reports·2014
Same author

Interfering with RAS-effector protein interactions prevent RAS-dependent tumour initiation and causes stop-start control of cancer growth.

Oncogene·2010

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chromosomal abnormalities in tumors were identified late last century.
  • Their role in cancer development is now increasingly understood.
  • Specific translocations are hallmarks of certain leukemias and solid tumors.

Purpose of the Study:

  • To elucidate the role of chromosomal abnormalities in cancer etiology.
  • To highlight the significance of fusion proteins as oncogenic drivers.
  • To explore the therapeutic potential of tumor-specific fusion proteins.

Main Methods:

  • Analysis of chromosomal translocations in various tumor types.
  • Identification and characterization of resulting fusion proteins.
  • Investigation of the functional impact of these proteins on cellular processes.

Main Results:

  • Chromosomal translocations frequently activate proto-oncogenes or form novel fusion proteins.
  • These fusion proteins often function as transcription factors, disrupting normal gene regulation.
  • Fusion proteins are common across diverse tumor types and act as unique tumor antigens.

Conclusions:

  • Disruption of transcriptional control via fusion proteins is a key mechanism in cancer development.
  • Tumor-specific fusion proteins offer potential as targeted therapeutic strategies.

Related Experiment Videos